Medicamen Organics Complete Financial Statements
MEDIORG • Review detailed financials to uncover trends, confirm thesis & journal trades
2 Years of Data
2025 - 2024
Complete Financial Data Export
Export complete financial statements for Medicamen Organics (MEDIORG).
Downloads include all available records across all periods.
For market performance, see the
MEDIORG stock price today
.
Profitability Ratios
Net Profit Margin
10.53%
2025 data
EBITDA Margin
18.42%
2025 data
Operating Margin
17.00%
2025 data
Return on Assets
6.78%
2025 data
Return on Equity
12.90%
2025 data
Balance Sheet Ratios
Current Ratio
22.50
2025 data
Debt to Equity
1.90
2025 data
Equity Ratio
52.54%
2025 data
Asset Turnover
0.64
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+55.3%
Year-over-Year
Equity Growth
+106.7%
Year-over-Year
Liabilities Growth
+55.3%
Year-over-Year
Operating Cash Flow Growth
-25.0%
Year-over-Year
Financing Cash Flow Growth
+175.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 |
|---|---|---|---|
| Revenue | 0 | 38 | 25 |
| Expenses | 0 | 32 | 21 |
| EBITDA | 0 | 7 | 5 |
| Operating Profit Margin % | 0.00% | 17.00% | 19.00% |
| Depreciation | 0 | 1 | 1 |
| Interest | 0 | 1 | 1 |
| Profit Before Tax | 0 | 5 | 4 |
| Tax | 0 | 1 | 2 |
| Net Profit | 0 | 4 | 3 |
| Earnings Per Share (₹) | 0.00 | 3.67 | 3.47 |
Related Pages for Medicamen Organics
Additional stock information and data for MEDIORG
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 |
|---|---|---|
| ASSETS | ||
| Total Assets | 59 | 38 |
| Current Assets | 45 | 27 |
| Fixed Assets | 10 | 10 |
| Capital Work in Progress | 2 | 0 |
| Investments | 0 | 0 |
| Other Assets | 47 | 28 |
| LIABILITIES | ||
| Total Liabilities | 59 | 38 |
| Current Liabilities | 2 | 2 |
| Non-Current Liabilities | ||
| SHAREHOLDERS' EQUITY | ||
| Total Equity | 31 | 15 |
| Share Capital | 12 | 9 |
| Reserves & Surplus | 18 | 7 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 |
|---|---|---|
| Operating Activities | -5 | -4 |
| Investing Activities | -2 | 0 |
| Financing Activities | 11 | 4 |
| Net Cash Flow | 4 | 0 |